Financial Review: Codex DNA (DNAY) and Its Rivals
Codex DNA (NASDAQ:DNAY – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it compare to its competitors? We will compare Codex DNA to related companies based on the strength of its dividends, analyst recommendations, valuation, profitability, risk, earnings and institutional ownership. Institutional & Insider Ownership 87.6% of […]